377 related articles for article (PubMed ID: 32417957)
1. Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy.
Kodama S; Kato S; Hayakawa K; Azuma M; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kosuge M; Kimura K; Tamura K
Heart Vessels; 2020 Oct; 35(10):1439-1445. PubMed ID: 32417957
[TBL] [Abstract][Full Text] [Related]
2. Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.
Azuma M; Kato S; Sekii R; Kodama S; Kinoshita K; Suzurikawa K; Kagimoto M; Nakayama N; Iguchi K; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K
Int J Cardiovasc Imaging; 2021 Aug; 37(8):2535-2543. PubMed ID: 33725266
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the cardiac magnetic resonance derived extracellular volume fraction and feature tracking myocardial strain in patients with non-ischemic dilated cardiomyopathy.
Azuma M; Kato S; Kodama S; Hayakawa K; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K
Magn Reson Imaging; 2020 Dec; 74():14-20. PubMed ID: 32898651
[TBL] [Abstract][Full Text] [Related]
4. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
[TBL] [Abstract][Full Text] [Related]
5. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy.
Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A
J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI.
Görmeli CA; Özdemir ZM; Kahraman AS; Yağmur J; Özdemir R; Çolak C
Radiol Med; 2017 Feb; 122(2):106-112. PubMed ID: 27785679
[TBL] [Abstract][Full Text] [Related]
8. The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy.
Hiraiwa H; Okumura T; Sawamura A; Sugiura Y; Kondo T; Watanabe N; Aoki S; Ichii T; Kitagawa K; Kano N; Fukaya K; Furusawa K; Morimoto R; Takeshita K; Bando YK; Murohara T
J Cardiol; 2018 Mar; 71(3):284-290. PubMed ID: 29066100
[TBL] [Abstract][Full Text] [Related]
9. Native T1 heterogeneity for predicting reverse remodeling in patients with non-ischemic dilated cardiomyopathy.
Kinoshita M; Kato S; Kodama S; Azuma M; Nakayama N; Fukui K; Saito N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
Heart Vessels; 2022 Sep; 37(9):1541-1550. PubMed ID: 35320392
[TBL] [Abstract][Full Text] [Related]
10. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
[TBL] [Abstract][Full Text] [Related]
11. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.
Youn JC; Hong YJ; Lee HJ; Han K; Shim CY; Hong GR; Suh YJ; Hur J; Kim YJ; Choi BW; Kang SM
Eur Radiol; 2017 Sep; 27(9):3924-3933. PubMed ID: 28439651
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
[TBL] [Abstract][Full Text] [Related]
14. Machine learning to predict left ventricular reverse remodeling by guideline-directed medical therapy by utilizing texture feature of extracellular volume fraction in patients with non-ischemic dilated cardiomyopathy.
Suyama S; Kato S; Nakaura T; Azuma M; Kodama S; Nakayama N; Fukui K; Utsunomiya D
Heart Vessels; 2023 Mar; 38(3):361-370. PubMed ID: 36056933
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of non-ischemic dilated cardiomyopathy by late iodine enhancement using rapid kV switching dual-energy computed tomography: A feasibility study.
Ohta Y; Kitao S; Yunaga H; Watanabe T; Mukai-Yatagai N; Kishimoto J; Yamamoto K; Ogawa T
J Cardiovasc Comput Tomogr; 2019; 13(2):148-156. PubMed ID: 30392925
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
[TBL] [Abstract][Full Text] [Related]
17. T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study.
Li S; Zhou D; Sirajuddin A; He J; Xu J; Zhuang B; Huang J; Yin G; Fan X; Wu W; Sun X; Zhao S; Arai AE; Lu M
JACC Cardiovasc Imaging; 2022 Apr; 15(4):578-590. PubMed ID: 34538631
[TBL] [Abstract][Full Text] [Related]
18. The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death.
Brembilla-Perrot B; Terrier de la Chaise A; Jacquemin L; Beurrier D; Houplon P
Am J Cardiol; 1997 Jan; 79(2):154-9. PubMed ID: 9193015
[TBL] [Abstract][Full Text] [Related]
19. Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
Al-Wakeel-Marquard N; Seidel F; Herbst C; Kühnisch J; Kuehne T; Berger F; Klaassen S; Messroghli DR
Int J Cardiol; 2021 Jun; 333():219-225. PubMed ID: 33737165
[TBL] [Abstract][Full Text] [Related]
20. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
